SCHEMBL5069038

SCHEMBL5069038

CN(C)C(F)(CCCCN)C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 2/20 0.40
CHRM4 P08173 2/20 0.40
CHRM5 P08912 2/20 0.40
CHRM1 P11229 2/20 0.40
CHRM3 P20309 2/20 0.40
ODC1 P11926 2/20 0.40
LMNA P02545 3/20 0.38
BLM P54132 3/20 0.38
KDM4E B2RXH2 1/20 0.38
MAPT P10636 1/20 0.38
RAB9A P51151 1/20 0.38
PMP22 Q01453 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CYP2D6 P10635 1/20 0.35
NFKB1 P19838 1/20 0.35
GSR P00390 1/20 0.35
NPSR1 Q6W5P4 2/20 0.34
THRB P10828 2/20 0.34
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6151309 0.82 ODC1 (0.41) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL6151308 0.82 ODC1 (0.41) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL7940896 0.81 ODC1 (0.44) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL29001334 0.76 ODC1 (0.43) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL157457 0.74 ODC1 (0.37) CHRM2ODC1LMNABLMKDM4E
SCHEMBL181191 0.74 ODC1 (0.37) CHRM2ODC1LMNABLMKDM4E
SCHEMBL30156940 0.74 ODC1 (0.37) CHRM2ODC1LMNABLMKDM4E
SCHEMBL27989280 0.74 ODC1 (0.37) CHRM2ODC1LMNABLMKDM4E
Hydrochloric Acid SCHEMBL21225312 0.73 BLM (0.39) ODC1LMNABLMKDM4EMAPT
Water SCHEMBL21225404 0.73 ODC1 (0.36) CHRM2ODC1LMNABLMKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080292548-A1 COMPOUNDS AND METHODS FOR 18F LABELED AGENTS Lantheus Biosciences Ltd. (GB) 2008-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080292548-A1 COMPOUNDS AND METHODS FOR 18F LABELED AGENTS QPCT, GBA2, GBA1 CHRM2 2319/4885CHRM4 3008/4885CHRM5 1477/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.